A

Anhui Huaren Health Pharmaceutical Co Ltd
SZSE:301408

Watchlist Manager
Anhui Huaren Health Pharmaceutical Co Ltd
SZSE:301408
Watchlist
Price: 12.51 CNY 2.04% Market Closed
Market Cap: 5B CNY
Have any thoughts about
Anhui Huaren Health Pharmaceutical Co Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

31.5
Current
29.8
Median
8.5
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
31.5
=
Enterprise Value
6.3B CNY
/
EBITDA
200.6m CNY
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
N/A
2-Years Forward
EV/EBITDA
N/A
3-Years Forward
EV/EBITDA
N/A

See Also

Discover More